DRNA

Dicerna to Announce First Quarter 2014 Financial Results and Host Conference Call on May 13, 2014

[Business Wire] – Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, will report its first quarter 2014 financial results on May 13, 2014. Dicerna will host a conference call and live audio webcast on May 13, 2014, at moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who […]

Dicerna Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)

[Business Wire] – Dicerna Pharmaceuticals, Inc. , a leader in the development of RNAi-based therapeutics, today announced that it granted stock options to Pankaj Bhargava, M.D., the Company’s chief medical officer, on April 16, 2014, including a stock op moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is hiring […]

Tech correction clouds IPO prospects

[at Financial Times] – Now you see it, now you don’t. The recent boom and sudden gloom for dozens of newly listed US technology companies is perfectly illustrated by the case of Dicerna Pharmaceuticals . Three months ago the … moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is […]

Dicerna to Announce Fourth Quarter 2013 Financial Results and Host Conference Call on March 27, 2014

[at noodls] – WATERTOWN, Mass.–(BUSINESS WIRE)– Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, will report its fourth quarter 2013 financial results on March … moreView todays social media effects on DRNAView the latest stocks trending across Twitter. Click to view dashboardSee who Dicerna is hiring next, click here to view […]